Financhill
Sell
40

EIPAF Quote, Financials, Valuation and Earnings

Last price:
$18.66
Seasonality move :
3.01%
Day range:
$18.66 - $18.66
52-week range:
$12.56 - $19.34
Dividend yield:
6.24%
P/E ratio:
19.03x
P/S ratio:
0.62x
P/B ratio:
0.96x
Volume:
1.8K
Avg. volume:
18.1K
1-year change:
31.41%
Market cap:
$55.6B
Revenue:
$96.1B
EPS (TTM):
$0.98

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Eni SpA has -- downside to fair value with a price target of -- per share.

EIPAF vs. S&P 500

  • Over the past 5 trading days, Eni SpA has underperformed the S&P 500 by -0.72% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Eni SpA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Eni SpA has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Eni SpA reported revenues of $23.6B.

Earnings Growth

  • Eni SpA has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Eni SpA reported earnings per share of $0.31.
Enterprise value:
82.2B
EV / Invested capital:
0.80x
Price / LTM sales:
0.62x
EV / EBIT:
11.61x
EV / Revenue:
0.88x
PEG ratio (5yr expected):
1.22x
EV / Free cash flow:
18.96x
Price / Operating cash flow:
13.44x
Enterprise value / EBITDA:
5.33x
Gross Profit (TTM):
$5.7B
Return On Assets:
2.06%
Net Income Margin (TTM):
3.45%
Return On Equity:
5.4%
Return On Invested Capital:
3.22%
Operating Margin:
7.18%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $106.6B $97.4B $93.7B $22.7B $23.6B
Gross Profit $8.2B $8.3B $5.7B $1.3B $1.3B
Operating Income $9.2B $10.3B $7.1B $1.7B $1.7B
EBITDA $17.3B $18.7B $15.4B $3.7B $3.8B
Diluted EPS $1.66 $0.85 $0.98 $0.18 $0.31
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $63.6B $83B $48B $46.4B $46.4B
Total Assets $156.3B $174.5B $149.3B $155.5B $158.6B
Current Liabilities $51.8B $70.8B $33.4B $36.6B $39.8B
Total Liabilities $109.7B $117.8B $88.6B $95.9B $96.4B
Total Equity $46.7B $56.7B $60.6B $59.7B $62.2B
Total Debt $33.8B $27.3B $31.9B $35B $33.7B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $16.5B $14.7B $14B $3.2B $3.8B
Cash From Investing -$10.3B -$10B -$8.5B -$1.8B -$1.9B
Cash From Financing -$8.1B -$4.7B -$5.7B -$2.3B -$2.1B
Free Cash Flow $6.6B $5.3B $4.3B $996.4M $1.1B
EIPAF
Sector
Market Cap
$55.6B
$40.1M
Price % of 52-Week High
96.48%
71.05%
Dividend Yield
6.24%
0%
Shareholder Yield
12.36%
0.13%
1-Year Price Total Return
31.41%
-1.76%
Beta (5-Year)
0.601
0.455
Dividend yield:
6.24%
Annualized payout:
$1.05
Payout ratio:
146%
Growth streak:
4 years

Technicals

8-day SMA
Sell
Level $18.80
200-day SMA
Buy
Level $16.65
Bollinger Bands (100)
Buy
Level 17.22 - 18.86
Chaikin Money Flow
Buy
Level 5.5M
20-day SMA
Sell
Level $18.72
Relative Strength Index (RSI14)
Buy
Level 51.77
ADX Line
Buy
Level 14.64
Williams %R
Neutral
Level -76.4045
50-day SMA
Buy
Level $18.34
MACD (12, 26)
Buy
Level 0.11
25-day Aroon Oscillator
Buy
Level 44
On Balance Volume
Sell
Level -4.2M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.462)
Sell
CA Score (Annual)
Level (-0.7248)
Buy
Beneish M-Score (Annual)
Level (-2.9314)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-0.2564)
Buy
Piotroski F Score (Annual)
Level (4)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Eni SpA engages in the exploration, production, refining, and sale of oil, gas, electricity, and chemicals. It operates through the following segments: Exploration and Production, Global Gas and LNG Portfolio, Refining & Marketing and Chemicals, Power & Renewables, and Corporate and Other Activities. The Exploration and Production segment engages in research, development and production of oil, condensates and natural gas, forestry conservation (REDD+) and CO2 capture and storage projects. The Global Gas and LNG Portfolio segment refers to the supply and sale of wholesale natural gas by pipeline, international transport and purchase and marketing of LNG, which includes gas trading activities finalized to hedging and stabilizing the trade margins, as well as optimizing the gas asset portfolio. The Refining & Marketing and Chemicals segment engages in supply, processing, distribution, and marketing of fuels and chemicals. The Corporate and Other Activities segment includes the main business support functions in particular holding, central treasury, IT, human resources, real estate services, captive insurance activities, research and development, new technologies, business digitalization, and environmental activities. The company was founded on February 10, 1953 and is headquartered in Rome, Italy.

Stock Forecast FAQ

In the current month, EIPAF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EIPAF average analyst price target in the past 3 months is --.

  • Where Will Eni SpA Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Eni SpA share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Eni SpA?

    Analysts are divided on their view about Eni SpA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Eni SpA is a Sell and believe this share price will rise from its current level to --.

  • What Is Eni SpA's Price Target?

    The price target for Eni SpA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is EIPAF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Eni SpA is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of EIPAF?

    You can purchase shares of Eni SpA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Eni SpA shares.

  • What Is The Eni SpA Share Price Today?

    Eni SpA was last trading at $18.66 per share. This represents the most recent stock quote for Eni SpA. Yesterday, Eni SpA closed at $18.66 per share.

  • How To Buy Eni SpA Stock Online?

    In order to purchase Eni SpA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 2.44% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 3.73% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock